Tipirneni Praveen P. 4
4 · Morphic Holding, Inc. · Filed Jul 10, 2024
Insider Transaction Report
Form 4
Tipirneni Praveen P.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2024-07-08−21,582→ 339,561 totalExercise: $4.32Exp: 2028-12-14→ Common Stock (21,582 underlying) - Sale
Common Stock
2024-07-08$55.79/sh−21,582$1,204,075→ 42,460 total - Exercise/Conversion
Common Stock
2024-07-08$4.32/sh+21,582$93,128→ 64,042 total
Footnotes (4)
- [F1]Includes 447 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 29, 2024.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.79 to $55.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The option is fully vested.